Navigation Links
Platelet Rich Plasma Therapy (PRP) Accelerates Healing of Joint Injuries, Osteoarthritis Pain

PRP Uses The Patient's Own Blood to Speed Tissue Regeneration and Healing according to Dr. Steven Sampson.

Los Angeles (PRWEB) June 19, 2009 -- According to Dr. Steven Sampson, Medical Director of the Orthohealing Center in Los Angeles (, Platelet Rich Plasma (PRP) therapy offers a promising solution to accelerate healing of tendon injuries and osteoarthritis naturally without subjecting the patient to significant risk.

As a result of Americans being increasingly active, physicians are seeing phenomenal numbers of patients suffering with knee and hip arthritis at younger ages than ever. In fact the demand for total knee replacements is expected to rise by 673% to 3.48 million procedures by 2030.

There is a shortage of licensed orthopaedic physicians that can meet patient needs. Additionally there is a trend where many Orthopaedists are not performing total joint replacements because of reduced reimbursement rates. As a result there is an urgent calling for new solutions to manage this growing patient population.

PRP Therapy is a relatively simple, non-surgical treatment for joint Injuries & arthritis. It uses the patient's own blood to speed tissue regeneration and healing.

"PRP is an emerging treatment in the new health sector of 'Orthobiologics,' which includes stem cells", says Dr. Sampson. "The philosophy is to merge cutting-edge technology with the body's natural ability to heal itself."
(See Attached images showing tendon regeneration with PRP therapy.)

Dr. Sampson hosts an informative blog covering the latest developments in PRP therapy which may be visited at

Platelet Rich Plasma or PRP is blood plasma with concentrated platelets. The concentrated platelets found in PRP contain huge reservoirs of bioactive proteins, including growth factors that are vital to initiate and accelerate tissue repair and regeneration. These bioactive proteins initiate connective tissue healing: bone, tendon and ligament regeneration and repair, promote development of new blood vessels, and stimulate the wound healing process.

Blood is made of RBC (Red Blood Cells), WBC (White Blood Cells), Plasma, and Platelets. Through a process known as centrifugation, the components not responsible for tissue repair are removed and the platelets remain. When in their resting state, platelets look like sea sponges and when activated form branches. Platelets were initially known to be responsible for blood clotting. In the last 20 years physicians have learned that when activated in the body, platelets release healing proteins called growth factors.

There are many growth factors with varying responsibilities, however cumulatively they accelerate tissue and wound healing. Some of the growth factors have been linked to cartilage regeneration. Therefore after increasing the baseline concentration of these platelets, we are able to deliver a powerful cocktail of growth factors that can dramatically enhance tissue recovery.

To prepare PRP, a small amount of blood is taken from the patient. The blood is then placed in a centrifuge. The centrifuge spins and automatically produces the PRP. The entire process takes less than 15 minutes and increases the concentration of platelets and growth factors over 500%.

When PRP is injected into the damaged area it stimulates the tendon or ligament causing mild inflammation that triggers the healing cascade. As a result new cells develop with restored blood flow and tissue regeneration occurs.

Elite athletes including Hines Ward of the Pittsburgh Steelers and Takashi Saito of the Los Angeles Dodgers have received this treatment with decreased return to play times without adverse effects. However the treatment is not restricted to high level athletes, it may ultimately see more widespread use in the weekend warrior.

PRP injections can be performed in tendons, ligaments, and painful joints all over the body. Sports injuries including rotator cuff tears, Achilles tendonitis, plantar fasciitis, knee meniscus tears, and hip & knee arthritis all may be effectively treated with PRP. Many patients have been able to avoid surgery with PRP treatment.

Case history -
"T.R." is a male professional pole-vaulter who competes in senior-level events (age 50-plus). He initially presented with complaints of knee pain from arthritis. He tried anti-inflammatories, received multiple synvisc and cortisone injections, and underwent arthroscopic surgery; however he continued to experience pain while jogging.

A musculoskeletal ultrasound was performed & identified multiple abnormalities of the knee which were contributing to his pain in addition to the arthritis.

After a series of 3 PRP injections to his pes anserine bursa, patellar tendon, medial meniscus and knee joint, he was pain free with no limitation. Several months later he received PRP therapy for his rotator cuff tear with arthritis and is doing great.

Patient testimony:
"As a national-class masters track and field athlete competing in the pole vault, sprints, and hurdles, decades of training and competition had worn down my joints to the point where running was painful and lifting my arm over my head was difficult. My orthopedist referred me to Dr. Sampson, whose assessment indicated that PRP for my problematic joints (knee, shoulder) might yield some benefits. Dr. Sampson gave me a series of PRP injections in the knee and the shoulder over an extended time. The improvement has been dramatic; I can run and pole vault without pain, train with intensity, and compete without worrying about joint limitations. PRP has returned my joint functionality to where it was 15 years ago."

# # #

Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Children's National Research Links Platelets to Sepsis-Related Organ Failure
2. Portola Pharmaceuticals Enters Worldwide License Agreement for Development and Commercialization of Novel Antiplatelet Drug Elinogrel
3. Bioreactors might solve blood-platelet supply problems
4. Novel therapeutic approaches may improve patient outcomes in several platelet disorders
5. Cardiogenesis Announces Preliminary Results Combining TMR + Platelet Rich Plasma (PRP)
6. GlaxoSmithKline Files for FDA Approval of PROMACTA(TM) (eltrombopag) to be the First Oral Platelet Growth Factor for Rare Blood Disorder
7. Rigel R788 Raises Platelet Counts in Immune Thrombocytopenic Purpura (ITP) Patients in Phase 2 Study
8. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
9. Falling Platelet Counts May Signal HIV-Linked Dementia
10. PEAK Surgical Announces First Use of PEAK PlasmaBlade(TM) in Europe
11. PEAK Surgical Announces Positive Fascia Incision Healing Results From Preclinical Study of PEAK PlasmaBlade(TM) for Gynecologic Surgery
Post Your Comments:
Related Image:
Platelet Rich Plasma Therapy (PRP) Accelerates Healing of Joint Injuries, Osteoarthritis Pain
(Date:11/30/2015)... ... November 30, 2015 , ... Holcomb ... the leading plastic surgery practices in Florida, is proud to announce that Dr. ... surgical innovations giant Ethicon Inc., a Johnson & Johnson Company. , Ethicon is ...
(Date:11/30/2015)... ... November 30, 2015 , ... The successful filing of an Investigational New Drug ... so important to this key industry segment, Regis Technologies has decided to sponsor and ... 4th at 11am EST. , Federal law does not allow new drugs to cross ...
(Date:11/30/2015)... ... November 30, 2015 , ... Healthjump, Inc. ... Inc., a Healthcare IT consulting, development and support company. The purchase will expand ... available within DataTrade to extend the services currently provided by Healthjump. ...
(Date:11/30/2015)... ... November 30, 2015 , ... GKhair & Tibolli team members and artists were ... held on November 8th and 9th at the Puerto Rico Convention Center, San Juan ... beauticians and top of the line fashion journalists. The San Juan Beauty Show carries ...
(Date:11/30/2015)... ... 2015 , ... Innovaacom, a leading provider of medical education ... of educational needs for pharmacists worldwide. The poll of pharmacists in Europe, Asia, ... online and face-to-face education for pharmacists who are fast becoming the new “gatekeepers” ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... HANOVER, N.J. , Nov. 30, 2015  Novartis ... portfolio at the 57 th American Society of ... leukemias, lymphomas and myelomas as well as supportive care, ... in addition to personalized cell therapies. The ASH Annual ... Orlando, Florida . Novartis Oncology . ...
(Date:11/30/2015)... and BOSTON , November 30, 2015 ... develop potential new medicines directed at up to 10 ... --> PFE ) to research and develop ... protein-coupled receptor (GPCR) targets across multiple therapeutic areas. ... drug discovery and development company and wholly-owned subsidiary of ...
(Date:11/30/2015)... 2015 Elbit Imaging Ltd. (TASE, ... today that it was informed by InSightec Ltd. ("InSightec"), that ... has approved its Exablate Neuro system to treat movement, ... --> Insightec,s Exablate Neuro platform is transforming ... two technologies: Focused Ultrasound, which is used to lesion ...
Breaking Medicine Technology: